Source comparison
How Is MK-677 Typically Administered in Research: Formulation Comparison
Powder (reconstituted) 10–25mg daily as liquid suspension Evening, 2+ hours post-meal 2–8°C refrigeration, light-protected 30 days post-reconstitution Higher preparation complexity; preferred in controlled inpatient settings where daily dosing is directly obse
This comparison does not assign a generated winner or score.
- Powder (reconstituted)
- 10–25mg daily as liquid suspension
- Evening, 2+ hours post-meal
- 2–8°C refrigeration, light-protected
- 30 days post-reconstitution
- Higher preparation complexity; preferred in controlled inpatient settings where daily dosing is directly observed
- Pre-dosed capsules
- 10–25mg daily per capsule
- Room temperature (20–25°C), sealed container
- 24 months from manufacture
- Superior stability and adherence; standard for multi-site outpatient trials where reconstitution errors introduce unacceptable variance
- Sublingual tablets (less common)
- 12.5–25mg daily
- Morning or evening, fasted state
- Room temperature, moisture-protected
- 18 months
- Faster absorption onset (15–20 min vs 45–60 min oral); niche use in studies measuring acute GH response curves